Lumida
/BHVN
⌘K
Biohaven Ltd

Biohaven Ltd

BHVN
$14.38USD+5.12%+0.70 today

MARKET CAP

2.2B

P/E (TTM)

FWD P/E

DAY RANGE

$14 – $15

52W RANGE

$7
$19

AI Summary

Stalk
Sell NowMedium

BHVN has broken below key support at the 50-day moving average, triggering a Support Failure pattern and now trades under its declining short-term EMAs. Short-term EMAs are sloping down, and price continues to reject at the EMA cluster, favoring selling on rallies into resistance. Medium-term bias remains bearish in Stage 4, while the long-term uptrend stays intact above the 200-day SMA. Timing aligns for immediate execution on failed rallies into EMAs.

  • Q4 net sales hit $190 M (+440% YoY) with 1.6 M+ prescriptions
  • Pfizer collaboration injects $500 M, boosting cash and overseas launch
  • Q4 adjusted net loss of $125 M and negative earnings yield
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICTREND
Sales, Adj.
YoY %
P / Sales
EV / Sales
Gross Profit, Adj.
YoY %
Margin %
EV / Gross Profit
EBITDA, Adj.
YoY %
Margin %
EV / EBITDA
EBIT
YoY %
Margin %
EV / EBIT
Net Income
YoY %
Net Margin
EPS (GAAP)
YoY %